These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29676606)

  • 1. Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices.
    Mariani S; Bertero L; Coppola V; Saracco G; Arezzo A; Francia Di Celle P; Metovic J; Marchiò C; Cassoni P
    Expert Rev Mol Diagn; 2018 May; 18(5):467-475. PubMed ID: 29676606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase.
    Do H; Dobrovic A
    Oncotarget; 2012 May; 3(5):546-58. PubMed ID: 22643842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening.
    Pérez-Báez W; García-Latorre EA; Maldonado-Martínez HA; Coronado-Martínez I; Flores-García L; Taja-Chayeb L
    Mol Cell Probes; 2017 Oct; 35():34-43. PubMed ID: 28627450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.
    Mariani S; Bertero L; Osella-Abate S; Di Bello C; Francia di Celle P; Coppola V; Sapino A; Cassoni P; Marchiò C
    Br J Cancer; 2017 Jul; 117(3):358-366. PubMed ID: 28618430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.
    Do H; Wong SQ; Li J; Dobrovic A
    Clin Chem; 2013 Sep; 59(9):1376-83. PubMed ID: 23649127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
    Hicks JK; Saller J; Wang E; Boyle T; Gray JE
    Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue.
    Fassunke J; Haller F; Hebele S; Moskalev EA; Penzel R; Pfarr N; Merkelbach-Bruse S; Endris V
    Int J Mol Med; 2015 Nov; 36(5):1233-43. PubMed ID: 26352389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
    Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
    J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.
    Kobunai T; Watanabe T; Yamamoto Y; Eshima K
    Biochem Biophys Res Commun; 2010 Apr; 395(1):158-62. PubMed ID: 20361930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-reproducible sequence artifacts in FFPE tissue: an experience report.
    Ofner R; Ritter C; Ugurel S; Cerroni L; Stiller M; Bogenrieder T; Solca F; Schrama D; Becker JC
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1199-1207. PubMed ID: 28314930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine.
    Kim S; Park C; Ji Y; Kim DG; Bae H; van Vrancken M; Kim DH; Kim KM
    J Mol Diagn; 2017 Jan; 19(1):137-146. PubMed ID: 27840062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.
    Serizawa M; Yokota T; Hosokawa A; Kusafuka K; Sugiyama T; Tsubosa Y; Yasui H; Nakajima T; Koh Y
    Cancer Genet; 2015 Sep; 208(9):415-27. PubMed ID: 26194062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of
    Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
    World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
    Kotoula V; Charalambous E; Biesmans B; Malousi A; Vrettou E; Fountzilas G; Karkavelas G
    PLoS One; 2009 Nov; 4(11):e7746. PubMed ID: 19888477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
    Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.